NEW YORK (MedPage Today) -- For those who might have lingering doubts, post-hoc analyses of two landmark statin trials -- PROVE-IT and IDEAL -- affirm the value of an intensive versus moderate approach to lipid-lowering, researchers here reported.
http://www.medpagetoday.com/Cardiology/Atherosclerosis/17456
--
This article was sent using my Viigo.
For a free download, go to http://getviigo.com
Sent from my Verizon Wireless BlackBerry
No comments:
Post a Comment